From Nikkei Asia · · 30s
Pharma firms cut Japan drug investments
Global pharma firms reduce innovative drug investments in Japan.
In brief
Global pharma firms reduce innovative drug investments in Japan. Global pharma firms are scaling back innovative drug research and production in Japan, risking medicine access. Originally reported by Nikkei Asia.
Global pharma firms
Global pharma firms walk back innovative drug investments in Japan.
Investment plans
35% of investment plans face downsizing or possible relocation.
Medicine access
Japan's ability to maintain stable medicine supply at risk.
At a glance
Global pharma firms are scaling back innovative drug research and production in Japan, risking medicine access.
